Log in to save to my catalogue

Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in n...

Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in n...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_19258320

Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells

About this item

Full title

Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2004-01, Vol.23 (1), p.311-316

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Patients with myeloid malignancies and either the 3q21q26 syndrome or t(1;3)(p36;q21) have been reported to share similar clinicopathological features and a common molecular mechanism for leukemogenesis. Overexpression of
MDS1/EVI1
(3q26) or
MEL1/PRDM16
(1p36), both members of the PR-domain family, has been directly implicated in the ma...

Alternative Titles

Full title

Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_19258320

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_19258320

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/sj.onc.1206923

How to access this item